| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.085 | 0.008 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.009 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.01 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.17 | 0.01 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |